Cargando…

Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis

SIMPLE SUMMARY: Solid tumor cells can lose or heterogeneously express antigens to become resistant to chimeric antigen receptor (CAR) T cell therapy. Here, we explore whether epigenetic manipulation to unleash antigen-independent killing mechanisms can overcome this hurdle. KDM1A is overexpressed in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sulejmani, Ornela, Grunewald, Laura, Andersch, Lena, Schwiebert, Silke, Klaus, Anika, Winkler, Annika, Astrahantseff, Kathy, Eggert, Angelika, Henssen, Anton G., Schulte, Johannes H., Anders, Kathleen, Künkele, Annette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583435/ https://www.ncbi.nlm.nih.gov/pubmed/34771652 http://dx.doi.org/10.3390/cancers13215489

Ejemplares similares

A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization
por: Grunewald, Laura, et al.
Publicado: (2021)

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing
por: Andersch, Lena, et al.
Publicado: (2019)

GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma
por: Zirngibl, Felix, et al.
Publicado: (2021)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

The Fas/FasL System in Reproduction: Survival and Apoptosis
por: Mor, Gil, et al.
Publicado: (2002)

Role of the Fas/FasL pathway in HIV or SIV disease
por: Poonia, Bhawna, et al.
Publicado: (2009)

CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus
por: Textor, Ana, et al.
Publicado: (2021)

Involvement of Fas/FasL pathway in the murine model of atopic dermatitis
por: Bień, Karolina, et al.
Publicado: (2017)

Fas/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation
por: Krzyzowska, Malgorzata, et al.
Publicado: (2021)

Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model
por: Ivasko, Sara Marie, et al.
Publicado: (2023)

Enhancing Production and Cytotoxic Activity of Polymeric Soluble FasL-Based Chimeric Proteins by Concomitant Expression of Soluble FasL
por: Morello, Aurore, et al.
Publicado: (2013)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Modulation of SIV and HIV DNA Vaccine Immunity by Fas-FasL Signaling
por: Yan, Jiabin, et al.
Publicado: (2015)

The signaling pathways by which the Fas/FasL system accelerates oocyte aging
por: Zhu, Jiang, et al.
Publicado: (2016)

Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance
por: Yamada, Akiko, et al.
Publicado: (2017)

FasL Modulates Expression of Mmp2 in Osteoblasts
por: Svandova, Eva, et al.
Publicado: (2018)

Human FasL Gene Is a Target of β-Catenin/T-Cell Factor Pathway and Complex FasL Haplotypes Alter Promoter Functions
por: Wu, Jianming, et al.
Publicado: (2011)

HSV-2 Regulates Monocyte Inflammatory Response via the Fas/FasL Pathway
por: Krzyzowska, Malgorzata, et al.
Publicado: (2013)

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC
por: Abed, Sally, et al.
Publicado: (2017)

Fas/FasL pathway and cytokines in keratinocytes in atopic dermatitis – Manipulation by the electromagnetic field
por: Szymanski, Lukasz, et al.
Publicado: (2018)

Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies
por: Sremec, Josip, et al.
Publicado: (2020)

Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4(+) CAR T Cell Efficacy
por: Ali, Solin, et al.
Publicado: (2020)

FasL Is Required for Osseous Healing in Extraction Sockets in Mice
por: Apaza Alccayhuaman, Karol Alí, et al.
Publicado: (2021)

Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection
por: Krzyzowska, M, et al.
Publicado: (2011)

Osteocalcin triggers Fas/FasL-mediated necroptosis in adipocytes via activation of p300
por: Otani, Takahito, et al.
Publicado: (2018)

Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens
por: Flores-Mendoza, Giovanna, et al.
Publicado: (2021)

Plasma Levels of sFas-sFasL and FASL Gene Expression Are Associated with Tuberculosis
por: Souza, Iury de Paula, et al.
Publicado: (2022)

Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis
por: Lin, Jing, et al.
Publicado: (2023)

Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes
por: Coe, Genevieve L., et al.
Publicado: (2016)

Fas/FasL Pathway Participates in Regulation of Antiviral and Inflammatory Response during Mousepox Infection of Lungs
por: Bień, Karolina, et al.
Publicado: (2015)

Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis
por: Huang, Donghua, et al.
Publicado: (2018)

Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells
por: Carnevale, Gianluca, et al.
Publicado: (2017)

Quantitative assessment of the relationship between Fas/FasL genes polymorphisms and head and neck cancer risk
por: Zhang, Dan-Feng, et al.
Publicado: (2018)

Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease
por: Cubero, Francisco Javier, et al.
Publicado: (2019)

Fas Ligand (FasL) in Association with Tumor-Infiltrating Lymphocytes (TILs) in Early Stage Cervical Cancer
por: Anggraeni, Tricia Dewi, et al.
Publicado: (2020)

Naja atra Cardiotoxin 1 Induces the FasL/Fas Death Pathway in Human Leukemia Cells
por: Chiou, Jing-Ting, et al.
Publicado: (2021)

Antiinflammatory Effects of CD95 Ligand (FasL)-induced Apoptosis
por: Gao, Yakun, et al.
Publicado: (1998)

In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression
por: Teiti, Iotefa, et al.
Publicado: (2015)

Reverse signaling by FasL inhibits primary human T cell activation
por: Paulsen, M, et al.
Publicado: (2009)

FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders
por: Ozdemirkiran, Fusun Gediz, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n3chdb4gap76ndnfe1ms40ajee